Lipid management options for patients have expanded significantly in the last several years. This has been great for patient outcomes, but the delivery mechanisms of the newer pharmacologic therapies are complex. Health care provider administered therapies and patient self-administered injectable therapies have tested operational structures and, for some, have been too daunting for widespread adoption. MedAxiom seeks to better understand the challenges in order to develop appropriate tools and resources for effective implementation of appropriate lipid management. Please take a few minutes to share insights on your current offerings and challenges related to managing patients with dyslipidemia – no data or program specifics required. Take the survey here.